A5028347938- Cancer survivorship and care
- Family and Disability Support Research
- Childhood Cancer Survivors' Quality of Life
- Innovations in Medical Education
- Geological Formations and Processes Exploration
- Methane Hydrates and Related Phenomena
- Educational and Psychological Assessments
- Acute Myeloid Leukemia Research
- Nutrition and Health in Aging
- Early Childhood Education and Development
- Health Sciences Research and Education
- Primary Care and Health Outcomes
- Parental Involvement in Education
- Psychological Well-being and Life Satisfaction
- Religion, Spirituality, and Psychology
- Adolescent and Pediatric Healthcare
- Geological Modeling and Analysis
- Resilience and Mental Health
- Histone Deacetylase Inhibitors Research
- Atrial Fibrillation Management and Outcomes
- Health and Medical Research Impacts
- Palliative Care and End-of-Life Issues
- Cancer-related cognitive impairment studies
University of Rochester Medical Center
2021-2024
Deutsches Herzzentrum der Charité
2017
Abstract Introduction: A national survey characterized training and career development for translational researchers through Clinical Translational Science Award (CTSA) T32/TL1 programs. This report summarizes program goals, trainee characteristics, mentorship practices. Methods: web link to a voluntary was emailed 51 active TL1 directors administrators. Descriptive analyses were performed on aggregate data. Qualitative data analysis used open coding of text followed by an axial strategy...
Abstract Patients with acute myeloid leukemia (AML) often undergo physical decline leading to negative outcomes. Identification of distinct trajectories may help guide clinical decision-making and supportive care interventions. We built group-based trajectory models (GBTM) find change in the Functional Assessment Cancer Therapy Physical Well-Being (FACT-PWB) subscale (up 5 time points over 0 200 days follow-up) using data from adults newly diagnosed AML 4 studies. also estimated association...
e19040 Background: Adults with acute myeloid leukemia (AML) commonly experience physical decline related to their disease and treatment which is associated negative outcomes. However, trajectories differ among patients. Identifying distinct may help guide clinical decision making supportive care interventions. In this secondary analysis, we examined of patients AML factors these trajectories. Methods: We used data from newly diagnosed in four trials. Functional Assessment Cancer Therapy...